Apolipoprotein A-II Is Inversely Associated With Risk of Future Coronary Artery Disease | Zendy

Rakesh S. Birjmohun | Zendy; Geesje M. DallingaThie | Zendy; Jan Albert Kuivenhoven | Zendy; Erik S.G. Stroes | Zendy; James D. Otvos | Zendy; Nicholas J. Wareham | Zendy; Robert Luben | Zendy; John J.P. Kastelein | Zendy; KayTee Khaw | Zendy; S. Matthijs Boekholdt | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Apolipoprotein A-II Is Inversely Associated With Risk of Future Coronary Artery Disease

Author(s) -

Rakesh S. Birjmohun,

Geesje M. DallingaThie,

Jan Albert Kuivenhoven,

Erik S.G. Stroes,

James D. Otvos,

Nicholas J. Wareham,

Robert Luben,

John J.P. Kastelein,

KayTee Khaw,

S. Matthijs Boekholdt

Publication year - 2007

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.107.704031

Subject(s) - medicine , coronary artery disease , cardiology , apolipoprotein b , disease , atherosclerotic cardiovascular disease , risk factor , cholesterol

Although the vasculoprotective effects of apolipoprotein A-I (apoA-I), the major protein associated with high-density lipoprotein, have been universally accepted, apoA-II has been suggested to have poor antiatherogenic or even proatherogenic properties. To study this suggestion more closely, we evaluated how serum levels of apoA-II and apoA-I relate to the risk of future coronary artery disease (CAD) in a large, prospective study.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research